/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Slow March
Updated 6.23.21, 11:09 AM EDT on neoscope
Study: Sorry, Aging Is Unstoppable, You Vain, Youth-Hungry Idiots
Cancer Vaccine
6.21.21, 1:52 PM EDT on neoscope
First Patient Injected With Cancer Vaccine in Phase II Trial
Shake On It
6.17.21, 5:10 PM EDT on neoscope
Pee Test Could Diagnose Brain Cancer, Scientists Say
Get Vaccinated!
6.17.21, 11:59 AM EDT on neoscope
UK Delays Reopening Over Alarming Spread of Delta COVID Variant
FOREBODING AF
Updated 6.16.21, 2:28 PM EDT on neoscope
Robot Skin Now Gets Bruised When Punched, Horrifyingly
All for One
6.16.21, 11:59 AM EDT on neoscope
International Vaccine Program Still Struggling After Rich Countries Hoard Shots
House Calls
6.15.21, 11:55 AM EDT on neoscope
New Tech Could Take Doctors Out of Hospitals Completely
Revising History
6.15.21, 11:04 AM EDT on neoscope
New Data: COVID Reached the US Earlier Than We Thought
Please?
6.14.21, 5:18 PM EDT on neoscope
Experts Beg World Leaders To Actually Learn Lessons From Pandemic, Please
Free Lunch
6.14.21, 3:26 PM EDT on neoscope
Free School Lunch Linked To Better Health, Higher Salary
Shot Number Four
Updated 6.14.21, 12:35 PM EDT on neoscope
A New Type of COVID Vaccine Is 90 Percent Effective
Vice City
6.14.21, 10:59 AM EDT on neoscope
Go Read This Essay on Managing Video Game Addiction
  • Previous
  • 1
  • ...
  • 118
  • 119
  • 120
  • ...
  • 213
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.